Profusa, Inc. SEC filings PFSA
Profusa, Inc. has 323 filings in SEC EDGAR's recent list, going back to Jun 17, 2021. Its latest annual report, Form ARS, was filed on May 26, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (material agreement, new debt, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| NT 10-Q | Notification of late filing | Aug 14, 2026 | Jun 30, 2026 |
| EFFECT | Filing | May 4, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 30, 2026 | — |
| NT 10-K | Notification of late filing | Apr 1, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Mar 3, 2026 | — |
| EFFECT | Filing | Feb 17, 2026 | — |
| EFFECT | Filing | Feb 17, 2026 | — |
| CORRESP | Letter to the SEC | Feb 17, 2026 | — |
| CORRESP | Letter to the SEC | Feb 13, 2026 | — |
| CORRESP | Letter to the SEC | Feb 13, 2026 | — |
| UPLOAD | Letter from the SEC | Feb 10, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 29, 2026 | — |
| DRS | Filing | Jan 29, 2026 | — |
| NT 10-Q | Notification of late filing | Nov 14, 2025 | Sep 30, 2025 |
| EFFECT | Filing | Sep 26, 2025 | — |
| CORRESP | Letter to the SEC | Sep 24, 2025 | — |
| CORRESP | Letter to the SEC | Sep 16, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2025 | — |
| EFFECT | Filing | Aug 25, 2025 | — |
| CORRESP | Letter to the SEC | Aug 21, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2025 | — |
| CERT | Filing | Jul 11, 2025 | — |
| 8-A12B | For registration of certain classes of securities | Jul 11, 2025 | — |
| 8-A12B | For registration of certain classes | Jun 18, 2025 | — |
| 425 | Current report | Jun 9, 2025 | — |
| 25-NSE | Delisting notice | May 22, 2025 | — |
| NT 10-Q | Notification of late filing | May 19, 2025 | Mar 31, 2025 |
| 425 | Current report | May 15, 2025 | — |
| SEC STAFF LETTER | Filing | May 14, 2025 | — |
| EFFECT | Filing | May 14, 2025 | — |
| CORRESP | Letter to the SEC | May 13, 2025 | — |
| CORRESP | Letter to the SEC | May 12, 2025 | — |
| UPLOAD | Letter from the SEC | May 12, 2025 | — |
| CORRESP | Letter to the SEC | May 8, 2025 | — |
| CORRESP | Letter to the SEC | Apr 25, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 18, 2025 | — |
| CORRESP | Letter to the SEC | Apr 3, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 7, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 28, 2025 | — |
| CORRESP | Letter to the SEC | Feb 27, 2025 | — |
| PRER14A | Revised preliminary proxy statement | Feb 27, 2025 | — |
| CORRESP | Letter to the SEC | Feb 26, 2025 | — |
| 425 | Current report | Feb 19, 2025 | — |
| CORRESP | Letter to the SEC | Feb 11, 2025 | — |
| NT 10-Q | Notification of late filing | Nov 15, 2024 | Sep 30, 2024 |
| NT 10-Q | Notification of late filing | Aug 22, 2024 | Jun 30, 2024 |
| SEC STAFF LETTER | Filing | May 23, 2024 | — |
| NT 10-Q | Filing | May 15, 2024 | Mar 31, 2024 |
| CORRESP | Letter to the SEC | May 10, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2024 | — |
| 425 | Form 425 | Apr 8, 2024 | — |
| CORRESP | Letter to the SEC | Mar 29, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 25, 2024 | — |
| 425 | Current report | Mar 14, 2024 | — |
| CORRESP | Letter to the SEC | Mar 5, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2024 | — |
| 425 | Form 425 | Jan 29, 2024 | — |
| 425 | Current report | Jan 22, 2024 | — |
| CORRESP | Letter to the SEC | Jan 16, 2024 | — |
| NT 10-Q | Notification of late filing | Nov 14, 2023 | Sep 30, 2023 |
| UPLOAD | Letter from the SEC | Nov 13, 2023 | — |
| CORRESP | Letter to the SEC | Oct 30, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 23, 2023 | — |
| CORRESP | Letter to the SEC | Oct 6, 2023 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2023 | — |
| 425 | Filing | Sep 13, 2023 | — |
| CORRESP | Letter to the SEC | Sep 12, 2023 | — |
| UPLOAD | Letter from the SEC | Aug 9, 2023 | — |
| CORRESP | Letter to the SEC | Jul 21, 2023 | — |
| UPLOAD | Letter from the SEC | May 31, 2023 | — |
| NT 10-Q | Filing | May 15, 2023 | Mar 31, 2023 |
| CORRESP | Letter to the SEC | May 11, 2023 | — |
| 425 | Filing | Mar 2, 2023 | — |
| UPLOAD | Letter from the SEC | Feb 21, 2023 | — |
| 425 | Form 425 | Jan 26, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2023 | — |
| CORRESP | Letter to the SEC | Dec 22, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 1, 2022 | — |
| 425 | Current report | Nov 10, 2022 | — |
| 425 | Form 425 | Nov 7, 2022 | — |
| 25-NSE | Delisting notice | Jan 21, 2022 | — |
| EFFECT | Filing | Dec 20, 2021 | — |
| CORRESP | Letter to the SEC | Dec 17, 2021 | — |
| CORRESP | Letter to the SEC | Dec 17, 2021 | — |
| CORRESP | Letter to the SEC | Dec 17, 2021 | — |
| CORRESP | Letter to the SEC | Dec 17, 2021 | — |
| CERT | Filing | Dec 17, 2021 | — |
| 8-A12B | For registration of certain classes | Dec 16, 2021 | — |
| CORRESP | Letter to the SEC | Dec 15, 2021 | — |
| CORRESP | Letter to the SEC | Dec 15, 2021 | — |
| CORRESP | Letter to the SEC | Dec 6, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 22, 2021 | — |
| CORRESP | Letter to the SEC | Aug 19, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 26, 2021 | — |
Showing 98 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PFSA (Nasdaq), NVACW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1859807
- Former names
- NorthView Acquisition Corp (until Jul 15, 2025)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.